• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MSD DEGGENDORF MFG CAPSTONE CONTROL SPINAL SYSTEM; INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MSD DEGGENDORF MFG CAPSTONE CONTROL SPINAL SYSTEM; INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT, Back to Search Results
Model Number 4011227
Medical Device Problem Code Mechanics Altered (2984)
Health Effect - Clinical Codes Undesired Nerve Stimulation (1980); Pain (1994)
Date of Event 06/23/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Information was received from a healthcare provider (hcp) via manufacturer representative regarding patient spinal therapy for sagital imbalance.It was reported that when the surgeon tried to implant the cage and turn it in order to take the final position, the implant released from the inserter and as result the implant didn¿t implanted according to the directions given in the ifu/labelling.There was patient had sciatica pain, nerve compression and no further complications were reported.
 
Additional Manufacturer Narrative
H3: product analysis #(b)(4).:part # 4011227, lot # 51ch visual and optical inspection confirmed the implant has been damaged.The body has been twisted and the inserter attachment hole has been deformed.This type of damage is consistent with bend stress overload.Radiographic image review: ap lateral x-ray for tlsi posterior lumbar spinal fusion.Ap/lateral x-rays interbody grafts present l4-5 l5-s1.The l5-s1 device appears positioned posteriorly in the interbody space.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPSTONE CONTROL SPINAL SYSTEM
Common Device Name
INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT,
Manufacturer (Section D)
MSD DEGGENDORF MFG
wertstrasse 17
deggendorf 94469
GM  94469
MDR Report Key12252355
Report Number1030489-2021-00994
Device Sequence Number3635133
Product Code MAX
UDI-Device Identifier00643169108844
UDI-Public00643169108844
Combination Product (Y/N)N
Initial Reporter CountryGR
PMA/510(K) Number
K120368
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/21/2024
Device Model Number4011227
Device Catalogue Number4011227
Device Lot Number51CH
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/23/2021
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/05/2021
Supplement Date Received by Manufacturer09/02/2021
Initial Report FDA Received Date07/30/2021
Supplement Report FDA Received Date09/29/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age69 YR
Patient Weight85
-
-